XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Significant Risks and Uncertainties Including Business and Credit Concentrations
 3 Months Ended
Mar. 31, 2025
Risks and Uncertainties [Abstract]  
Significant Risks and Uncertainties Including Business and Credit Concentrations Significant Risks and Uncertainties Including Business and Credit Concentrations
Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, accounts receivable, and investment securities.
Cash accounts in a financial institution may, at times, exceed the Federal Deposit Insurance Corporation coverage of $250 per account ownership category. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.
The Company’s accounts receivable has implicit collection risk. The Company grants credit without collateral to their patients, most of whom are local residents and are insured under third-party payor agreements. The Company believes this risk is partially mitigated by the Company’s establishment of long-term agreements and relationships with third-party payors that provide the Company with insight into historic collectability and improve the collections process.
Revenue Concentration Risk
The concentration of net revenue on a percentage basis for major payors for the three months ended March 31, 2025 and 2024 are as follows:

Three Months Ended March 31,
20252024
Percentage of Patient Services Net Revenue: 
Payor A15 %15 %
The concentration of gross receivables on a percentage basis for major payors at March 31, 2025 and December 31, 2024.
March 31, 2024December 31, 2024
Percentage of Gross Receivables of Patient Services Revenue: 
Payor A12 %N/A
All of the Company’s revenue is generated from customers located in the United States.
Vendor Concentration Risk
The concentration of cost of sales on a percentage basis for major vendors for the three months ended March 31, 2025 and 2024 are as follows:
Three Months Ended March 31,
20252024
Percentage of Direct Costs: 
Vendor A99 %98 %
The concentration of gross payables on a percentage basis for major payors at March 31, 2025 and December 31, 2024 are as follows:
March 31, 2025December 31, 2024
Percentage of Gross Payables:
Vendor A71 %65 %